Astera Labs (NASDAQ:ALAB) Shares Up 12.4% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB) rose 12.4% during mid-day trading on Monday . The company traded as high as $343.00 and last traded at $340.74. Approximately 6,070,613 shares changed hands during mid-day trading, an increase of 15% from the average session volume of 5,258,738 shares. The stock had previously closed at $303.25.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Needham & Company LLC raised their price target on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Bank of America boosted their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Roth Capital reaffirmed a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Finally, UBS Group reiterated a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Stock Up 12.4%

The company has a market capitalization of $59.11 billion, a PE ratio of 168.68 and a beta of 3.77. The company’s 50 day moving average is $303.33 and its two-hundred day moving average is $266.42.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Buying and Selling

In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the transaction, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the transaction, the general counsel owned 96,542 shares of the company’s stock, valued at $32,872,551. This represents a 6.58% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 592,244 shares of company stock valued at $209,729,973 in the last ninety days. Company insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several large investors have recently bought and sold shares of the business. Twin Peaks Capital Ltd bought a new position in Astera Labs during the second quarter valued at $4,830,000. Capstone Financial Advisors Inc. purchased a new position in shares of Astera Labs in the 2nd quarter worth $274,000. Sequoia Financial Advisors LLC increased its holdings in shares of Astera Labs by 19.0% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,677 shares of the company’s stock worth $1,776,000 after buying an additional 588 shares during the last quarter. Archford Capital Strategies LLC bought a new stake in shares of Astera Labs in the 2nd quarter worth about $506,000. Finally, Integrated Wealth Concepts LLC raised its position in shares of Astera Labs by 0.7% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock valued at $3,384,000 after buying an additional 52 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.